Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.

about

Goal-directed Hemostatic Resuscitation for Trauma Induced Coagulopathy : Maintaining Homeostasis.

P2860

Q50045370-28D56124-C9B1-4192-82EF-3667E06D924F

P2860

Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.

Item

http://www.wikidata.org/entity/Q38653755

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Tranexamic acid is associated ...... th physiological fibrinolysis.

@en

type

Item

label

Tranexamic acid is associated ...... th physiological fibrinolysis.

@en

prefLabel

Tranexamic acid is associated ...... th physiological fibrinolysis.

@en

P1476

Tranexamic acid is associated ...... th physiological fibrinolysis.

@en

P2093

Angela Sauaia

http://www.w3.org/2001/XMLSchema#string

Benjamin R Huebner

http://www.w3.org/2001/XMLSchema#string

Christopher C Silliman

http://www.w3.org/2001/XMLSchema#string

Ernest E Moore

http://www.w3.org/2001/XMLSchema#string

Geoffrey R Nunns

http://www.w3.org/2001/XMLSchema#string

Gregory R Stettler

http://www.w3.org/2001/XMLSchema#string

Hunter B Moore

http://www.w3.org/2001/XMLSchema#string

Peter M Einersen

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays

Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy.

Temporally and regionally disparate differences in plasmin activity by tranexamic acid.

A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis

Revisiting early postinjury mortality: are they bleeding because they are dying or dying because they are bleeding?

Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock.

Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy

P31

scholarly article

P356

10.1016/J.JSS.2017.04.028

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28755903

http://www.w3.org/2001/XMLSchema#string

P932

5677580

http://www.w3.org/2001/XMLSchema#string

Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.

about

P2860

P2860

Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P932